Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -6.78% | $ 351.32M | $ 23.83M |
3/31/2025 | -4.7% | $ 416.93M | $ 19.58M |
12/31/2024 | -4.92% | $ 319.87M | $ 15.75M |
9/30/2024 | -2.85% | $ 408.7M | $ 11.65M |
6/30/2024 | -1.21% | $ 374.47M | $ 4.54M |
3/31/2024 | -0.47% | $ 589.59M | $ 2.78M |
12/31/2023 | -0.26% | $ 667.57M | $ 1.72M |
9/30/2023 | -0.26% | $ 1.03B | $ 2.72M |
6/30/2023 | -0.56% | $ 560.54M | $ 3.12M |
3/31/2023 | -2.13% | $ 633.59M | $ 13.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 31.15M ]) / Market Cap [ $ 1.11B ]
(=) Buyback Yield [ -2.8% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |